Back To: Home : Featured Technology : Assay Development

CLICK HERE FOR WHAT'S NEW IN:
 

Universal, Label-free, Cell-based Assay Technology, MDS Sciex
October 2005
SHARING OPTIONS:

MDS Sciex, the analytical instruments division of MDS Inc., launched the CellKey System for measurement of endogenous cell surface receptor activation in live cells and gneration of data that enables identification of the receptor coupling mechanism of unknown receptors (e.g., orphan G protein-coupled receptors). The CellKey System is based on cellular dielectric spectroscopy (CDS's) technology, an approach that removes the requirement for fluorescent or radio-labeled markers from the drug discovery workflow, thereby simplifying assay development. The sensitivity of CDS' impedance-based measurement system enables the measurement of receptor targets in whole live cells and the generation of data that is more biorelevant than in other cellular screening systems. MDS Sciex claims that this system can simplify assay design activities, address many of the bottlenecks currently experienced within secondary screening and lead optimization, and ultimately enable researchers to develop important new medicines more rapidly.
 
MDS Sciex
866-MYSCIEX

Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.